TCW GROUP INC

Position in LLY — ELI LILLY & Co

CIK 850401 LOS ANGELES, CA

Position in LLY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$19,282,037

+$7,175,105 QoQ

Shares Held

16,076

+22.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#904

of 4,605 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TCW GROUP INC holds $339,099,387 across 10 Drug Manufacturers - General names. LLY ranks #5 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	845,538	$108,651,633
2	ABBV	AbbVie Inc.	359,980	$90,585,366
3	PFE	Pfizer Inc	2,669,765	$64,287,940
4	AZN	Astrazeneca PLC	142,573	$27,034,691
5	LLY	ELI LILLY & Co This page	16,076	$19,282,037
6	JNJ	Johnson & Johnson	51,246	$13,014,946
7	AMGN	Amgen Inc	28,369	$10,272,981
8	GILD	Gilead Sciences, Inc.	27,425	$3,464,874

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,282,037	16,076	+22.1%	Shares	Defined	2026-08-03
2026-03-31	$12,106,932	13,163	+0.2%	Shares	Defined	2026-05-14
2025-12-31	$14,124,519	13,143	-42.4%	Shares	Defined	2026-02-17
2025-06-30	$17,772,503	22,799	+60.5%	Shares	Defined	2025-08-14
2025-03-31	$11,730,398	14,203	+12.8%	Shares	Defined	2025-05-07
2024-12-31	$9,718,708	12,589	+8.7%	Shares	Defined	2025-02-04
2024-09-30	$10,257,413	11,578	-2.3%	Shares	Defined	2024-11-19
2024-06-30	$10,731,469	11,853	+4.1%	Shares	Defined	2024-07-19
2024-03-31	$8,857,074	11,385	-14.8%	Shares	Defined	2024-05-10
2023-12-31	$7,788,394	13,361	-23.5%	Shares	Defined	2024-02-09
2021-03-31	$3,261,503	17,458	-20.7%	Shares	Defined	2021-05-05
2020-12-31	$3,715,830	22,008	0.0%	Shares	Defined	2021-02-02
2020-09-30	$3,257,624	22,008	0.0%	Shares	Defined	2020-10-30
2020-06-30	$3,613,273	22,008	-2.3%	Shares	Defined	2020-08-05
2020-03-31	$3,123,835	22,519	—	Shares	Defined	2020-05-05
No filing history on record for this holder in this stock.